total hiparthroplasty
Conditions
Interventions
Group NB :Inject 20ml of 0.5% ropivacaine into the aponeurosis of the external oblique muscle + inject 20ml of 0.25% ropivacaine into the inguinal iliac fascia space
Control Group:Injection of 0.25% ropivacaine 20ml into the inguinal level iliac fascia space
Sponsors
The First Affiliated Hospital of Anhui Medical University
Eligibility
Sex/Gender
All
Age
40 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1) Patients undergoing elective hip replacement surgery in our hospital from December 2020 to February 2021; 2) Aged 40 to 75 years old; 3) ASA I to III level; 4) The subject voluntarily participates in the study and has signed an informed consent form.
Exclusion criteria
Exclusion criteria: 1) Evidence of severe cardiovascular, kidney, blood or liver disease; 2) Pre-existing history of psychological or mental illness; 3) History of dependence on painkillers; 4) Those who have contraindications to the regional block technique (allergy to local anesthetics, infection around the puncture site and coagulation disorders). 5) Communication difficulties.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Total amount of remifentanil used during surgery; | — |
Secondary
| Measure | Time frame |
|---|---|
| Intraoperative hemodynamic indicators (systolic blood pressure, diastolic blood pressure, mean arterial pressure, heart rate);Postoperative pain score; | — |
Contacts
Public ContactGuang-hong Xu
The First Affiliated Hospital of Anhui Medical University
Outcome results
None listed